Capsule
DETRUSITOL SR PROLONGED-RELEASE CAPSULES 2MG
Summary
DETRUSITOL SR PROLONGED-RELEASE CAPSULES 2MG — Capsule containing tolterodine tartrate. Hong Kong Registration No. HK-66981. Certificate Holder: VIATRIS HEALTHCARE HONG KONG LIMITED. Date of Registration: 05 Feb, 2021.
Product NameDETRUSITOL SR PROLONGED-RELEASE CAPSULES 2MG
Registration No.HK-66981
Certificate HolderVIATRIS HEALTHCARE HONG KONG LIMITED
Holder AddressSUITES 2401-07 & 12, 24/F, ONE ISLAND EAST, 18, WESTLANDS ROAD, QUARRY BAY, HONG KONG
Ingredientstolterodine tartrate
Dosage FormCapsule
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration05 Feb, 2021
ATC codesG04BD07
ATC Classification
ATC level 1
G Genito Urinary System and Sex Hormones
All ATC groupsG04
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。